120 mg/5 ml, oral suspension
Paracetamolum
for infants and children
Important information for the patient.
This medicine should always be taken exactly as described in this patient information leaflet or as directed by your doctor or pharmacist.
Paracetamol Hasco, oral suspension is an antipyretic and analgesic medicine intended for use in infants and children. When used in recommended doses, it is well tolerated.
Indications for use are fever and pain of various origins (e.g., after surgical procedures, pain associated with teething, headache of mild or moderate severity) and discomfort accompanying the body's reaction to vaccination (pain, fever, local reaction).
In addition, the medicine is used in infants from 0 to 3 months of age for the symptomatic treatment of fever lasting no longer than 3 days and pain of mild to moderate severity.
Before starting to take Paracetamol Hasco, you should discuss it with your doctor or pharmacist.
Do not take with other medicines containing paracetamol due to the risk of overdose. In case of overdose, consult your doctor immediately, even if you feel well.
Do not take for more than 3 days without consulting your doctor.
Do not take doses larger than recommended.
The medicine should be used with caution in patients with liver and kidney failure.
During treatment with this medicine, do not drink alcoholic beverages, and do not take the medicine if you are addicted to alcohol.
There is a particularly high risk of liver damage in people who are fasting.
In patients with asthma, allergic to acetylsalicylic acid, there may be an allergy to paracetamol.
Available study results indicate that the administration of paracetamol may be a risk factor for the development of asthma and allergic diseases in children.
During treatment with Paracetamol Hasco, you should immediately inform your doctor if you have severe illnesses, including severe kidney dysfunction or sepsis (when bacteria and their toxins circulate in the blood, leading to organ damage) or malnutrition, chronic alcoholism, or if you are taking flucloxacillin (an antibiotic). In these situations, patients have been reported to develop a severe disease called metabolic acidosis (a disorder of blood and body fluids), when they took paracetamol in regular doses for a longer period or when they took paracetamol with flucloxacillin. Symptoms of metabolic acidosis may include: severe breathing difficulties, including rapid deep breathing, drowsiness, feeling of nausea (nausea) and vomiting.
You should tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take.
The medicine should not be taken with centrally acting analgesics or with alcohol, as it enhances their effect. When taken together: barbiturates, antiepileptic drugs (including glutethimide, phenobarbital, phenytoin, carbamazepine), rifampicin, it increases the harmful effect of paracetamol on the liver. Paracetamol increases the toxicity of chloramphenicol.
Prolonged use of paracetamol in high doses enhances the effect of oral anticoagulant drugs from the coumarin group.
Concomitant use of paracetamol with nonsteroidal anti-inflammatory drugs increases the risk of kidney function disorders.
You should inform your doctor or pharmacist if you are taking flucloxacillin (an antibiotic) due to the serious risk of blood and body fluid disorders (called metabolic acidosis), which must be urgently treated (see section 2).
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking this medicine.
Women who are pregnant or breastfeeding can take this medicine if, in the doctor's opinion, it is necessary.
Paracetamol Hasco has no influence or negligible influence on the ability to drive and use machines.
The medicine contains 3112.4 mg of sucrose in each 5 ml of oral suspension. This should be taken into account in patients with diabetes. If you have previously been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medicine.
The medicine contains 6.82 mg of sodium benzoate in each 5 ml of oral suspension. Sodium benzoate may increase the risk of jaundice (yellowing of the skin and whites of the eyes) in newborns (up to 4 weeks of life).
The medicine may rarely cause severe hypersensitivity reactions and bronchospasm.
Paracetamol Hasco contains less than 1 mmol (23 mg) of sodium per 5 ml of oral suspension, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as described in this patient information leaflet or as directed by your doctor or pharmacist. If you are unsure, you should consult your doctor or pharmacist.
The medicine is taken orally.
Before use, shake the bottle vigorously to obtain a uniform suspension.
If your doctor does not recommend otherwise, the average single dose of paracetamol is 10 mg to 15 mg per kilogram of body weight.
If necessary, the dose can be repeated, but not more often than every 4-6 hours, up to 4 times a day, i.e., a maximum of 60 mg/kg body weight per day.
Age (child's body weight) | Recommended single dose | Maximum daily dose |
from 0 to 3 months of age (up to 4 kg) | 2.5 ml (60 mg) | 10 ml (240 mg) |
from 4 to 8 months of age (up to 7 kg) | 4 ml (96 mg) | 16 ml (384 mg) |
from 9 to 11 months of age (up to 8 kg) | 5 ml (120 mg) | 20 ml (480 mg) |
from 1 to 2 years of age (up to 10.5 kg) | 6.5 ml (156 mg) | 26 ml (624 mg) |
from 2 to 3 years of age (up to 13 kg) | 8 ml (192 mg) | 32 ml (768 mg) |
from 4 to 5 years of age (up to 18.5 kg) | 12 ml (288 mg) | 48 ml (1152 mg) |
from 6 to 8 years of age (up to 24 kg) | 15 ml (360 mg) | 60 ml (1440 mg) |
from 9 to 10 years of age (up to 32 kg) | 20 ml (480 mg) | 80 ml (1920 mg) |
from 11 to 12 years of age (up to 45.6 kg) | 28.5 ml (684 mg) | 114 ml (2736 mg) |
Do not take for more than 3 days without consulting your doctor.
Use in children under 2 years of age should be prescribed by a doctor.
A measuring cup or measuring spoon or a plug and oral syringe are attached to the packaging.
Instructions for dosing with an oral syringe:
There are no special instructions for taking with food.
If you feel that the effect of Paracetamol Hasco is too strong or too weak, you should consult your doctor.
In case of accidental administration or ingestion of a higher dose of the medicine than recommended, you should immediately contact your doctor.
Severe poisoning may occur in children after ingestion of 200 mg of paracetamol/kg body weight.
Accidental or intentional overdose of paracetamol may cause, within a few or several hours, symptoms such as: nausea, vomiting, excessive sweating, drowsiness, and general weakness. These symptoms may subside the next day, despite the slow development of severe liver damage, manifested by a feeling of fullness in the upper abdomen, nausea, and jaundice.
Treatment of paracetamol poisoning must be carried out in a hospital, under intensive medical care. If it has not been more than an hour since the ingestion of paracetamol, you should induce vomiting and administer activated charcoal.
Do not take a double dose to make up for a missed dose.
If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Rarely (in less than 1 in 1000 people): skin allergic reactions: hives, rash, skin inflammation.
Very rarely (in less than 1 in 10,000 people): decreased platelet count (thrombocytopenia), white blood cell count (leukopenia, agranulocytosis); nausea, vomiting, diarrhea.
Frequency not known (cannot be estimated from the available data): a serious disease that can cause blood acidification (so-called metabolic acidosis), in patients with severe illness taking paracetamol (see section 2).
The medicine taken for a longer period or overdosed may cause liver and kidney damage and methemoglobinemia with symptoms of cyanosis (gray-blue skin discoloration).
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw
tel.: 22 49-21-301, fax: 22 49-21-309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store in the original package, in a closed container, at a temperature below 25°C. Do not freeze.
The medicine should be stored out of sight and reach of children.
Do not take this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The medicine is a milky to light yellow oral suspension.
The packaging of the medicine consists of a 60 ml bottle containing 50 g of the medicine, made of colored glass with an HDPE cap and a LDPE plug and a guarantee seal. The bottle is placed in a cardboard box with a patient information leaflet and a measuring cup or measuring spoon or a plug and oral syringe with a capacity of 5 ml, graduated every 0.5 ml or an oral syringe with a capacity of 5 ml, graduated every 0.25 ml made of PE and polystyrene.
or
The packaging of the medicine consists of a 100 ml colored glass bottle containing 115 g of the medicine, closed with an aluminum cap. The bottle is placed in a cardboard box with a patient information leaflet and a measuring cup or measuring spoon.
or
The packaging of the medicine consists of a 125 ml bottle containing 150 g of the medicine, made of colored glass with an aluminum cap or an HDPE cap with a LDPE plug and a guarantee seal. The bottle is placed in a cardboard box with a patient information leaflet and a measuring spoon or a plug and oral syringe with a capacity of 5 ml, graduated every 0.5 ml or an oral syringe with a capacity of 5 ml, graduated every 0.25 ml made of PE and polystyrene.
"PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK" S.A.
51-131 Wrocław, ul. Żmigrodzka 242 E
tel.: (22) 742 00 22
e-mail: informacjaoleku@hasco-lek.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.